Sign Out
CRESEMBA is indicated in adults for the treatment of invasive aspergillosis; mucormycosis in patients for whom amphotericin B is inappropriate (see Precautions & Pharmacology: Pharmacodynamics under Actions).
Consideration should be given to official guidance on the appropriate use of antifungal agents.
Usage: Specimens for fungal culture and other relevant laboratory studies (including histopathology) to isolate and identify causative organism(s) should be obtained prior to initiating antifungal therapy. Therapy may be instituted before the results of the cultures and other laboratory studies are known depending on national guideline. However, once these results become available, antifungal therapy should be adjusted accordingly.
